NEW YORK (GenomeWeb News) – Bioinformatics services and consulting company Eagle Genomics plans to raise £1 million ($1.6 million) in new financing to support commercialization of its new cloud-based life sciences data analysis product and expansion of its staff.

Eagle Genomics CEO David Flanders told GenomeWeb Daily News today that the four-and a-half year-old firm, based at the Babraham Research Campus in Cambridge, UK, is looking to raise the equity from venture capital and angel investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.